SCHEMBL3575816

SCHEMBL3575816

O=C1NC(=O)c2ccccc2/C1=C/NNc1cccc(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.49
MAPT P10636 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 2/20 0.46
HSP90AA1 P07900 1/20 0.46
VCP P55072 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAB9A P51151 2/20 0.45
MAP2K7 O14733 2/20 0.43
CDC25B P30305 2/20 0.43
NSD2 O96028 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
CDC25A P30304 1/20 0.43
HTT P42858 1/20 0.43
MCL1 Q07820 1/20 0.43
ATM Q13315 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PSD A5PKW4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575821 1.00 GSK3B (0.49) GSK3BMAPTMEN1KMT2APOLB
SCHEMBL3570990 0.88 RAB9A (0.60) GSK3BMAPTMEN1KMT2APOLB
SCHEMBL3570992 0.88 RAB9A (0.60) GSK3BMAPTMEN1KMT2APOLB
SCHEMBL3572467 0.72 GSK3B (0.52) GSK3BMAPTMEN1KMT2AHSP90AA1
SCHEMBL3572468 0.72 GSK3B (0.52) GSK3BMAPTMEN1KMT2AHSP90AA1
Phthalimide SCHEMBL28353587 0.72 GSK3B (0.65) GSK3BMAPK1CASP3PIM1
SCHEMBL8834607 0.71 BRAF (0.66) GSK3BMAPTMEN1KMT2ARAB9A
SCHEMBL3574396 0.68 ALDH1A1 (0.42) GSK3BMAPTMEN1KMT2ARAB9A
SCHEMBL3574397 0.68 ALDH1A1 (0.42) GSK3BMAPTMEN1KMT2ARAB9A
SCHEMBL3564004 0.68 KMT2A (0.50) GSK3BMAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US claimed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US claimed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 GSK3B 4189/4885MAPT 4095/4885MEN1 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.